Cargando…
Integrating peripheral blood and brain transcriptomics to identify immunological features associated with Alzheimer’s disease in mild cognitive impairment patients
BACKGROUND: Immune system dysfunction has been proven to be an important pathological event in Alzheimer’s disease (AD). Mild cognitive impairment (MCI), as a transitional stage between normal cognitive function and AD, was an important research object for the screening of early diagnostic markers a...
Autores principales: | Qian, Xiao-hang, Liu, Xiao-li, Chen, Sheng-di, Tang, Hui-dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501700/ https://www.ncbi.nlm.nih.gov/pubmed/36159817 http://dx.doi.org/10.3389/fimmu.2022.986346 |
Ejemplares similares
-
Peripheral reaching in Alzheimer's disease and mild cognitive impairment
por: Mitchell, Alexandra G., et al.
Publicado: (2022) -
Novel brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer’s disease and mild cognitive impairment
por: Huang, Jie
Publicado: (2022) -
Central and Peripheral Inflammation in Mild Cognitive Impairment in the Context of Alzheimer’s Disease
por: Schmidt-Morgenroth, Inès, et al.
Publicado: (2023) -
Differential Phenotypes of Myeloid-Derived Suppressor and T Regulatory Cells and Cytokine Levels in Amnestic Mild Cognitive Impairment Subjects Compared to Mild Alzheimer Diseased Patients
por: Le Page, Aurélie, et al.
Publicado: (2017) -
PT584. Peripheral inflammatory markers in Alzheimer’s disease and mild cognitive impairment
por: Kim, Yo Sup, et al.
Publicado: (2016)